ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0487

Interdialysis Blood Pressure Increase: Unexplored Relationships

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Diaz Cabral, Adolfo, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, CDMX, Mexico
  • Delgado Avila, Brenda Guadalupe, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, CDMX, Mexico
  • Argaiz, Eduardo R., Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, CDMX, Mexico
  • Vega, Olynka, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, CDMX, Mexico
  • Correa-Rotter, Ricardo, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, CDMX, Mexico
  • Rodriguez-Iturbe, Bernardo, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, CDMX, Mexico
Background

Dry weight increases due to water retention are associated to higher blood pressure (BP) and adverse cardiovascular effects in HD patients. However, weight changes between a dialysis session and the next one, do not have a predictable relation with the interdialytic BP changes. Inconsistencies may be due in part to unreliability of clinic BP measurements but factors other than fluid overload may also play a determinant role. We examined the association of interdialytic weight gain (IDWG) with serum angiotensin II (AngII), norepinephrine (NE), copeptin and inflammatory markers levels with the changes in clinic BP and mean interdialytic ambulatory blood pressure measurements (ABPM).

Methods

We studied 30 patients on regular and stable HD thrice weekly. Ultrafiltration was prescribed during HD, in order to reach the clinically estimated dry weight. ABPM was monitored during 23-44 hours in the interdialytic period. Predialysis serum samples were used for laboratory determinations. Three groups were defined according to ABPM.

Results

Table 1

Conclusion

AngII levels play an important role in hypertension of HD patients (correlation between ABPM and AngII levels r=0.42; 95% CI 0.07 to 0.70; p=0.02). There was no correlation between IDWG and AngII levels. Interdialysis blood pressure changes and mean interdialysis ambulatory blood pressure were unrelated to IDWG.

Results. Table 1.
 ABPM
MarkersA.<130(n=14)A.130-139 (n=8)A.≥140 (n=8)p
Interdialysis clinic SBP change (mmHg)10.5±4.49(0.8 to 20.2)-4.1±6.36*(-19.6 to 10.9)
23.9±10.02*(0.2 to 47.6)
*(B vs C)0.03
IDWG (% of dry weight, kg)2.85±0.38(2.0 to 3.7)3.43±0.66(1.86 to 4.98)
2.56±0.52(1.34 to 3.79)
0.533
Ang II (pg/ml)106.9±12.4&(80.1 to 133.6)178.0±35.5(94.1 to 262)
273.5±39.9&(129.2 to 317.9)
&(A vs C)0.011
Norepinephrine (pg/min)117.4±31.4(49.7 – 185.2)146.1±51.6(24.1 to 268)
140.5±52.2(17.1 to 263.9)
0.867
Copeptin (pg/ml)155.2±9.8 (n=11)(133.6 to 176.6)115.2±12.0 (n=7)(85.8 to 144.5)
154.2±20.3 (n=7)(104.6 to 203.9)
0.10
TNFα (pg/ml)20.7±6.36 (n=12)(6.70 to 34.7)20.3±7.50(2.56 to 38.0)
14.4±5.0 (n=6)(1.5 to 27.4)
0.845
Inflammation index0.88± 0.18(0.58 to 1.58)0.93±0.20 (n=7)(0.56 to 1.30)
1.07±1.12 (7)(0.56 to 1.30)0.71

Data are mean±SE (95%CI). p=one-way ANOVA and Tukey post-tests.

Digital Object Identifier (DOI)